THE TEAM

behind the investments

SANDS CAPITAL VENTURES TEAM

A bold mission requires a strong team. We sought out individuals who share our passion and have assembled a deep and diverse bench of investment, legal, operational, and financial personnel to execute on our mission.

Jennifer Dean

Executive Assistant

Jennifer joined Sands Capital Ventures in 2015 and serves as Executive Assistant, supporting all members of the Sands Capital Ventures team. Prior to Sands Capital Ventures, Jennifer was an Executive Assistant and Project Manager at Mars, Inc., gaining brand knowledge across many industries. Jennifer holds a B.A. in English from the University of Georgia.

Kumar Gautam

Senior Associate

Kumar joined Sands Capital Ventures in 2014, and supports the team’s research efforts in identifying, assessing, and monitoring investments in the Technology, internet, and Life Sciences sectors. Prior to joining Sands Capital Ventures, Kumar was a Senior Analyst at Altman Vilandrie & Company, a management consulting firm that advises businesses and investors in the information technology space. Kumar graduated cum laude from Dartmouth College with a degree in Computer Science.

Andrew Giordano

Director of Client Relations

Andrew joined Sands Capital in 2010 and is Director of Client Relations. Andrew began his career at Sands Capital supporting client relations efforts for public equity strategies, and his passion for the private space steered him to the Sands Capital Ventures team. Andrew has worked with Frank and Michael to implement Sands Capital’s client-first, white-glove service approach to our Partners. Andrew leads the team’s business development efforts and is the primary contact for all partner and prospective engagements. Andrew came to Sands Capital from Friedman, Billings, Ramsey Capital Markets where he spent six years supporting equity clients and cultivating relationships with hedge funds and long-only firms across the U.S. Andrew holds a B.A. from Middlebury College and MBAs from both Columbia University and London Business School.

Jonathan Goodman, JD

General Counsel and Chief Compliance Officer, SCV

General Counsel, SCM

Jonathan joined Sands Capital in 2012 and is General Counsel and Chief Compliance Officer of Sands Capital Ventures and General Counsel of Sands Capital Management. Jonathan is responsible for managing all aspects of Sands Capital Ventures’ legal and compliance matters, including fund formation, transaction execution, and regulatory compliance. Prior to joining Sands Capital, Jonathan was associated with Gibson, Dunn & Crutcher LLP and Cravath, Swaine & Moore, LLP, where he had extensive experience with private investment funds, mergers and acquisitions, capital markets transactions, and related regulatory regimes. Jonathan holds a B.A. from the University of Wisconsin at Madison and a juris doctor degree from the Georgetown University Law Center where he graduated magna cum laude and with the Order of the Coif designation.

Brad Howlett, CVA

Associate

Brad joined Sands Capital in 2015 and is an Associate for Sands Capital Ventures. Brad supports the team’s technology and global consumer due diligence efforts and provides operational leadership to the team through financial modeling, portfolio valuation, and his involvement with fund management. Prior to joining Sands Capital, Brad was a Senior Consultant on the Financial Advisory Services team at Baker Tilly Virchow Krause, LLP. Brad graduated with a B.S. in Commerce from the University of Virginia and holds a Certified Valuation Analyst designation.

Ian Ratcliffe

Partner

Ian is Partner of Sands Capital Ventures and joined in January 2016. He is a serial entrepreneur and has 20 years of experience starting and investing in life sciences technology businesses as an angel, venture and private equity investor. Ian has served in many roles as a founder, CEO, CFO, COO, chairman, director and advisor to a number of privately-held Life Science product and service businesses.  He has focused on the cell signaling, drug screening, genomics and sequencing, and cell culture and modification segments, at all stages of business development from initiation through profitability to trade sale. Prior to joining Sands Capital, Ian was the Chairman and CEO of Enzymatics Inc., founder and CEO of Stemgent, Inc., a stem and iPS cell life sciences tool, and President of Upstate Inc., a leading provider of cell signaling research products and services. Ian was also a founding investor in Firefly Bioworks and Genometry, both SCV investments. Ian has a degree in Chemical Engineering from University of Surrey and has an MBA from the Darden School at the University of Virginia.

Michael Rubin, MD, CFA

Managing Partner and Co-Founder

Michael is Managing Partner and co-Founder of Sands Capital Ventures. Michael joined Sands Capital in 2008, where he has had significant experience with life sciences and technology-empowered businesses as an angel, venture, private equity, and public equity investor. Michael has served as a director or advisor to a number of privately-held businesses. Prior to joining Sands Capital, Michael was a board certified and licensed ophthalmologist and completed post-graduate retina fellowship training at Harvard Medical School. Michael conducted molecular genetics research, and has written book chapters in leading texts, been published in peer review journals,  led multiple research groups, and participated in large industry sponsored clinical trials. Michael completed an ophthalmology residency at The University of Chicago. Michael is a graduate of The University of Chicago Pritzker School of Medicine, received his MBA from the University of Massachusetts Amherst, and a B.S. in electrical engineering from UCLA.

Frank Sands, CFA

Co-Founder, SCV

CIO and CEO, SCM

Frank is co-Founder of Sands Capital Ventures and Chief Executive Officer and Chief Investment Officer of Sands Capital Management. Frank joined Sands Capital Management in 2000 as Managing Director, Director of Research, Sr. Portfolio Manager. Frank has been Chief Executive Officer and Chief Investment Officer since 2008. Frank and Michael Rubin developed and executed their vision of Sands Capital Ventures and have grown the organization within Sands Capital Management. Prior to working at Sands Capital Management, Frank worked for Fayez Sarofim & Co., an institutional investment management firm based in Houston, Texas, for six years as a research analyst and portfolio manager. Frank earned a B.A. from Washington & Lee University, an M.S. from Johns Hopkins University, and an MBA from the Darden School at the University of Virginia.

Erin Soule, CPA

Director of Finance and Operations

Erin joined Sands Capital in 2014 and is Director of Finance and Operations for Sands Capital Ventures. Erin is responsible for managing all financial and accounting aspects of Sands Capital Ventures, including financial reporting and portfolio valuations, and manages various aspects of Sands Capital Ventures’ operations. In addition, Erin works closely with Sands Capital Ventures’ investment professionals on the financial due diligence process and portfolio construction. Prior to joining Sands Capital, Erin was a Vice President at American Capital, Ltd., where she had extensive experience with private equity investment underwriting, transaction execution, portfolio management and valuations, and internal controls. Erin began her career as an auditor at PricewaterhouseCoopers, LLP and worked with the Transaction Services team on buy-side and sell-side financial due diligence. Erin holds a B.S. in Accountancy from The College of New Jersey and is a Certified Public Accountant.

Stephen Zachary, PhD

Associate

Stephen joined Sands Capital in 2016 as an Associate for Sands Capital Ventures. Stephen participates in identifying, assessing, and monitoring investments, focusing primarily on the Life Sciences sector. Prior to joining Sands Capital, Stephen received his PhD in Neuroscience from Johns Hopkins School of Medicine. During graduate school, Stephen was awarded an NIH Fellowship and completed an externship in biotech equity research with T. Rowe Price. Stephen attended Columbia University for his postbaccalaureate studies and received a B.A. in Philosophy from Washington & Lee University.

SANDS CAPITAL
GLOBAL RESEARCH TEAM

Our dedicated Sands Capital Ventures team’s strengths are complemented by the Global Research Team’s deep domain experience across an array of industries. Both teams share a common focus: innovation and growth.